Dermatology · Redding, CA
NPI
1053300632
Since 2005
Specialty
Dermatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2107 Airpark Dr
Redding, CA, 96001
Phone (530) 241-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.0M
33,368 services
Medicare patients, 2024
5,594
Average age 76
Drug cost, 2024
$3.0M
1,752 prescriptions
Company payments, 2025
$119K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Craig A Kraffert was code 88305 (surgical pathology examination), 5,925 times for 3,859 patients. In total Craig A Kraffert billed 33,368 services in 130 codes, and Medicare paid $5.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 5,925 | 3,859 | $52.79 | $313K |
| 77280 Radiation Treatment Planning | Office | 5,421 | 329 | $226.74 | $1.2M |
| 0394T Conventional Radiation Treatment | Office | 5,391 | 327 | $131.02 | $706K |
| 77600 Radiation Oncology | Office | 4,738 | 327 | $456.77 | $2.2M |
| 17003 Destruction Skin Lesion | Office | 4,237 | 722 | $5.14 | $22K |
| 99213 Office E&M - Established | Office | 2,154 | 1,640 | $57.69 | $124K |
| 17000 Destruction Skin Lesion | Office | 1,060 | 917 | $35.22 | $37K |
| 17110 Destruction Skin Lesion | Office | 899 | 829 | $71.54 | $64K |
| 17004 Destruction Skin Lesion | Office | 410 | 339 | $125.61 | $51K |
| 99203 Office E&M - New | Office | 366 | 366 | $61.03 | $22K |
| 99214 Office E&M - Established | Office | 348 | 302 | $77.35 | $27K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 278 | 29 | $152.42 | $42K |
| 99212 Office E&M - Established | Office | 230 | 214 | $36.63 | $8,424 |
| 11102 Skin Biopsy | Office | 172 | 157 | $53.18 | $9,147 |
| 17281 Destruction Skin Lesion | Office | 171 | 139 | $116.33 | $20K |
By year: 2022 $829K for 16,717 services; 2023 $2.1M for 23,927 services; 2024 $5.0M for 33,368 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 5,925 | 3,859 | $52.79 | $313K |
Medicare prescription drug claims, 2024
In 2024, the drug Craig A Kraffert prescribed most often to Medicare patients was Doxycycline Hyclate, with 171 prescriptions and refills. In total Craig A Kraffert wrote 1,752 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 171 | 369 | 95 | $7,391 |
| Mometasone Furoate Generic | 157 | 160 | 122 | $2,786 |
| Dutasteride Generic | 156 | 464 | 55 | $8,681 |
| Dupixent Pen Dupilumab | 120 | 121 | 18 | $451K |
| Terbinafine Hcl Generic | 84 | 200 | 45 | $1,263 |
| Valacyclovir Valacyclovir Hcl | 83 | 178 | 33 | $4,231 |
| Fluticasone Propionate Generic | 76 | 77 | 57 | $990 |
| Imiquimod Generic | 74 | 88 | 57 | $2,423 |
| Dupixent Syringe Dupilumab | 65 | 65 | Under 11 | $234K |
| Taltz Autoinjector Ixekizumab | 52 | 62 | Under 11 | $416K |
| Gentamicin Sulfate Generic | 49 | 49 | 36 | $1,516 |
| Azithromycin Generic | 47 | 49 | 42 | $173 |
| Clindamycin Phosphate Generic | 38 | 39 | 11 | $1,107 |
| Tremfya Guselkumab | 38 | 71 | Under 11 | $510K |
| Ketoconazole Generic | 38 | 40 | 25 | $795 |
Brand drugs: 474 claims; generic drugs: 1,278 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig A Kraffert $119K ($119K in general payments such as food, travel and fees) from 16 companies. The largest payer was Galderma Laboratories, L.P. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 28 | $41K |
| Lilly USA, LLC LLY | 48 | $32K |
| UCB, Inc. UCB.BR | 37 | $28K |
| Janssen Biotech, Inc. JNJ | 16 | $8,696 |
| Abbvie Inc. ABBV | 42 | $7,121 |
| Genzyme Corporation SNY | 18 | $562 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $315 |
| LEO Pharma Inc. | 11 | $296 |
| Incyte Corporation INCY | 7 | $184 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $73.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.